{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:59:14Z","timestamp":1768031954821,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ajem.2021.04.088","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:31:34Z","timestamp":1620948694000},"page":"249-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Ferritin, fever, and frequent visits: Hyperferritinemic syndromes in the emergency department"],"prefix":"10.1016","volume":"48","author":[{"given":"Youssef","family":"Annous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danya","family":"Khoujah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinte.1992.00400130047001","article-title":"Fever of unknown origin. An old friend revisited","volume":"152","author":"Petersdorf","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2021.04.088_bb0010","first-page":"35","article-title":"Fever of unknown origin--reexamined and redefined","volume":"11","author":"Durack","year":"1991","journal-title":"Curr Clin Top Infect Dis"},{"issue":"6","key":"10.1016\/j.ajem.2021.04.088_bb0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00005792-199711000-00002","article-title":"Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group","volume":"76","author":"de Kleijn","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archinte.1992.00400130077008","article-title":"Fever of unknown origin in the 1980s. An update of the diagnostic spectrum","volume":"152","author":"Knockaert","year":"1992","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0025","first-page":"124","article-title":"One-year epidemiology of fever at the emergency department","volume":"69","author":"Limper","year":"2011","journal-title":"Neth J Med"},{"issue":"10","key":"10.1016\/j.ajem.2021.04.088_bb0030","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.amjmed.2015.06.001","article-title":"Fever of unknown origin: a clinical approach","volume":"128","author":"Cunha","year":"2015","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmedicine.18-2-170","article-title":"Pyrexia of unknown origin","volume":"18","author":"Fernandez","year":"2018","journal-title":"Clin Med (Lond)"},{"issue":"10","key":"10.1016\/j.ajem.2021.04.088_bb0040","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.ajem.2021.04.088_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.04.088_bb0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ajem.2021.04.088_bb0060","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2020.01130","article-title":"Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome an immunomodulatory perspective to alleviate the storm","volume":"11","author":"Ruscitti","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajem.2021.04.088_bb0065","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan","volume":"46","author":"Ruan","year":"2020","journal-title":"China Intensive Care Med"},{"issue":"10","key":"10.1016\/j.ajem.2021.04.088_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23618","article-title":"Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"34","author":"Cheng","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ajem.2021.04.088_bb0075","doi-asserted-by":"crossref","first-page":"603389","DOI":"10.3389\/fimmu.2020.603389","article-title":"Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences","volume":"11","author":"Meng","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajem.2021.04.088_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: the evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"SAGE Open Med"},{"issue":"12","key":"10.1016\/j.ajem.2021.04.088_bb0085","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1651-2227.2007.00564.x","article-title":"Ferritin levels in children with severe sepsis and septic shock","volume":"96","author":"Garcia","year":"2007","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still\u2019s disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ajem.2021.04.088_bb0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00296-010-1601-4","article-title":"Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience","volume":"32","author":"Lian","year":"2012","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still\u2019s disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0110","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.ajem.2021.04.088_bb0120","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","article-title":"Clinical features and prognosis in adult-onset Still\u2019s disease: a study of 104 cases","volume":"29","author":"Kong","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ajem.2021.04.088_bb0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"21\u221222","key":"10.1016\/j.ajem.2021.04.088_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4414\/smw.2005.10976","article-title":"Haemophagocytic syndromes in adults: current concepts and challenges ahead","volume":"135","author":"Emmenegger","year":"2005","journal-title":"Swiss Med Wkly"},{"issue":"9927","key":"10.1016\/j.ajem.2021.04.088_bb0135","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.ajem.2021.04.088_bb0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"10.1016\/j.ajem.2021.04.088_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0145-2126(98)00083-6","article-title":"Hemophagocytic syndrome associated with hematological neoplasias","volume":"22","author":"Majluf-Cruz","year":"1998","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.ajem.2021.04.088_bb0150","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.ajem.2021.04.088_bb0155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.ajem.2021.04.088_bb0160","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases","volume":"46","author":"Batu","year":"2017","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajem.2021.04.088_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OARRR.S151013","article-title":"Macrophage activation syndrome: early diagnosis is key","volume":"10","author":"Lerkvaleekul","year":"2018","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"10.1016\/j.ajem.2021.04.088_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","article-title":"Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis","volume":"44","author":"Kostik","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ajem.2021.04.088_bb0185","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ajem.2021.04.088_bb0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncprheum0919","article-title":"A case of macrophage activation syndrome successfully treated with anakinra","volume":"4","author":"Kelly","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ajem.2021.04.088_bb0200","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3899\/jrheum.091046","article-title":"Macrophage activation syndrome treated with anakinra","volume":"37","author":"Durand","year":"2010","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ajem.2021.04.088_bb0205","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society","volume":"6","author":"Ehl","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2021.04.088_bb0210","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ajem.2021.04.088_bb0215","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ajem.2021.04.088_bb0220","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodriguez-Pinto","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.ajem.2021.04.088_bb0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.ajem.2021.04.088_bb0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0002-9343(98)00061-8","article-title":"Thrombotic storm: when thrombosis begets thrombosis","volume":"104","author":"Kitchens","year":"1998","journal-title":"Am J Med"},{"issue":"3\u20134","key":"10.1016\/j.ajem.2021.04.088_bb0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0245","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J Rheumatol"},{"issue":"13","key":"10.1016\/j.ajem.2021.04.088_bb0250","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/0961203313504633","article-title":"Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)","volume":"22","author":"Agmon-Levin","year":"2013","journal-title":"Lupus."},{"issue":"1","key":"10.1016\/j.ajem.2021.04.088_bb0255","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11926-014-0482-z","article-title":"Catastrophic APS in the context of other thrombotic microangiopathies","volume":"17","author":"Rodriguez-Pinto","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.ajem.2021.04.088_bb0260","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus."},{"issue":"8","key":"10.1016\/j.ajem.2021.04.088_bb0265","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ajem.2021.04.088_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ajem.2021.04.088_bb0275","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2021.04.088_bb0280","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/096120339800700214","article-title":"The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment","volume":"7","author":"Asherson","year":"1998","journal-title":"Lupus"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721003752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721003752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:55:24Z","timestamp":1760025324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":56,"alternative-id":["S0735675721003752"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.04.088","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferritin, fever, and frequent visits: Hyperferritinemic syndromes in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.04.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}